Madrigal Pharmaceuticals (MDGL) Stock Highlights

308.79 | +2.01%

2025-04-24 02:12:30

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Statistics

Range Today

299.15 316.18

Volume Today 355.9K

Range 1 Year

189 377.46

Volume 1 Year 97.76M

Range 3 Year

57.15 377.46

Volume 3 Year 294.62M

Range 10 Year

5.25 377.46

Volume 10 Year 544.93M

Highlights

Market Capitalization 6.66B (mid)

Floating Shares 11.36M

Current Price 308.79

Price To Earnings -13.98

Price To Revenue 32.5

Price To Book 8.8

Earnings Per Share -21.9

Payout Ratio 0%

Performance

Latest +2.01%

1 Month -10.21%

3 Months -4.91%

6 Months +51.04%

1 Year +45.09%

3 Years +314.48%

5 Years +270.43%

10 Years +196.06%

Benchmarks

Market Capitalization

36 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

332 / 368

Free Cashflow

322 / 352

Performance 5 years

24 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.